ARID4B-B3GALNT2 Fusion FISH Probe
The ARID4B-B3GALNT2 Fusion FISH Probe is used to confirm a fusion of the ARID4B and B3GALNT2 genes. The fusion of the ARID4B and B3GALNT2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ARID4B-B3GALNT2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ARID4B-B3GALNT2-20-AQAQ | 20 (40 μL) | 200 μL |
|
ARID4B Gene Summary
This gene encodes a protein with sequence similarity to retinoblastoma-binding protein-1. The encoded protein is a subunit of the histone deacetylase-dependant SIN3A transcriptional corepressor complex, which functions in diverse cellular processes including proliferation, differentiation, apoptosis, oncogenesis, and cell fate determination. The gene product is recognized by IgG antibody isolated from a breast cancer patient and appears to be a molecular marker associated with a broad range of human malignancies. Alternate transcriptional splice variants encoding different isoforms have been characterized. [provided by RefSeq, Jul 2008]
Gene Name: AT-rich Interaction Domain 4B
Chromosome: CHR1: 235330209 -235491532
Locus: 1q42.3
B3GALNT2 Gene Summary
This gene encodes a member of the glycosyltransferase 31 family. The encoded protein synthesizes GalNAc:beta-1,3GlcNAc, a novel carbohydrate structure, on N- and O-glycans. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Mar 2013]
Gene Name: Beta-1,3-N-acetylgalactosaminyltransferase 2
Chromosome: CHR1: 235610532 -235667781
Locus: 1q42.3
Gene Diseases
The ARID4B B3GALNT2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|